-
-
-
-
-
-
-
Sanofi drug gets EU panel backing for progressive multiple sclerosis
-
-
-
-
-
-
-
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
-
-
-
-
-
-
-
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR11 at BofA Securities
-
-
-
-
-
-
-
Press Release: Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosis
-
-
-
-
-
-
-
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
-
-
-
-
-
-
-
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR7.20 at Citi, 'SAN shares are attractive'
-
-
-
-
-
-
-
Sanofi and Orano Join Forces to Develop Next-generation Radioligand Medicines
-
1,200,310 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

